| Stage | HCA | % of rev | ARDT | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $19.8B | 100.00% | $1.6B | 100.00% | HCA ×12.24 |
| Gross profit | $11.3B | 56.77% | $946M | 58.32% | ARDT +1.5pp |
| Operating income | $3.0B | 14.90% | $43M | 2.66% | HCA +12.2pp |
| Pre-tax income | $2.4B | 11.94% | $43M | 2.66% | HCA +9.3pp |
| Net income | $1.8B | 9.32% | $35M | 2.14% | HCA +7.2pp |
| Stage | HCA | ARDT | Gap · A − B |
|---|---|---|---|
| Revenue | $19.8B100.00% | $1.6B100.00% | HCA ×12.24 |
| Gross profit | 56.77%$11.3B | 58.32%$946M | ARDT +1.5pp |
| Operating income | 14.90%$3.0B | 2.66%$43M | HCA +12.2pp |
| Pre-tax income | 11.94%$2.4B | 2.66%$43M | HCA +9.3pp |
| Net income |
| 9.32%$1.8B |
| 2.14%$35M |
| HCA +7.2pp |